Top Research Reports for Amazon, Bank of America & Lockheed Martin
Friday, June 5, 2020
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Amazon.com (AMZN), Bank of America (BAC) and Lockheed Martin (LMT). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Amazon’s shares have outperformed the broader market over the past year (+40.3% vs. +9.5%). The Zacks analyst believes that Amazon is gaining on robust AWS services. Strong adoption rate of AWS is aiding its cloud dominance.
Further, AWS is gaining solid traction among healthcare workers, medical researchers, educational institutions and government organizations owing to coronavirus management measures. Further, Prime momentum owing to fast delivery services and strong content portfolio is benefiting Amazon.
Also, expanding distribution strength and workforce which are helping in addressing the overflowing online orders during this pandemic are major positives. Furthermore, robust Alexa skills and strong smart home product offerings are tailwinds. However, growing coronavirus related expenses might hurt Amazon’s profitability. Also, foreign exchange headwinds and rising cloud competition are risks.
(You can read the full research report on Amazon here >>>)
Shares of Bank of America have lost -20.4% over the past six months against the Zacks Major Regional Banks industry’s fall of -26.3%. The Zacks analyst believes that opening new branches, improved digital offerings and efforts to manage costs will likely aid profitability.
Additionally, strong balance sheet and liquidity position are expected to continue supporting the company's financials amid economic slowdown. However, near-zero interest rates are expected to hurt the bank’s margins and interest income.
Also, coronavirus-induced concerns will likely continue to hamper business activities and thus, loan growth is expected to be muted. Further, dependence on capital markets performance makes us apprehensive, given its cyclical nature. This is likely to hurt fee income growth to some extent
(You can read the full research report on Bank of America here >>>)
Lockheed Martin’s shares have gained +5.5% over the past three months against the Zacks Aerospace Defense industry’s fall of -9.4%. The Zacks analyst believes that expansionary budgetary provisions made by the current U.S. administration will immensely boost this defense prime's business. It continues to be a strong cash generator.
Lockheed Martin enjoys strong demand for its high-end military equipment in domestic and international markets, being the world’s largest defense contractor. However, Lockheed Martin faces intense global competition for its broad portfolio of products and services.
Furthermore, forced cost reduction initiatives for the F-35 program might hamper its operating results. America and Turkey’s tiff on the later accepting Russian products may hurt Lockheed’s component supply from Turkey. It is also facing performance issues in relation to some of its products, which in turn may hurt its results.
(You can read the full research report on Lockheed Martin here >>>)
Other noteworthy reports we are featuring today include Alphabet (GOOGL), Micron Technology (MU) and Charles Schwab (SCHW).
Today's Best Stocks from Zacks
Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2019, while the S&P 500 gained and impressive +53.6%, five of our strategies returned +65.8%, +97.1%, +118.0%, +175.7% and even +186.7%.
This outperformance has not just been a recent phenomenon. From 2000 – 2019, while the S&P averaged +6.0% per year, our top strategies averaged up to +54.7% per year.
See their latest picks free >>
Sheraz Mian
Director of Research
Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>
Today's Must Read
Growing AWS Adoption & Prime Momentum Benefit Amazon (AMZN)
Loan Growth, Branch Openings Aid BofA (BAC) amid Lower Rates
Order Growth Aids Lockheed (LMT), Turkey Tiff Poses Risk
Featured Reports
Alphabet (GOOGL) Rides on Diversification; Risks Remain
The Zacks analyst believes that Alphabet's improving search & advertising revenue, focus on cloud, hardware and AI, will continue to deliver growth.
Micron (MU) Benefits from Growing Memory-Chip Demand
Per the Zacks Analyst, Micron is growing on solid memory-chip demand from PC manufacturers and data-center operators.
Buyouts, Trading Focus Aid Schwab (SCHW) Amid Lower Rates
Per the Zacks analyst, strategic acquisitions and efforts to strengthen trading business will likely aid Schwab's profitability.
Growth Investments Supports ABB Despite Weak Market Demand
Per the Zacks analyst, ABB's organic growth investments and diligent cost-cutting initiatives will improve its competency.
New Products Boost General Dynamics (GD), Poor Budget Woes
Per the Zacks analyst, steady product innovations allow General Dyanmics to capture more defense market share.
Enterprise (EPD) Banks on $7.7B Major Midstream Projects
Enterprise will generate additional fee-based revenues from its $7.7 billion of key midstream projects. However, significant debt exposure concerns the Zacks analyst.
Segmental Growth Aids Walgreens (WBA) Amid Coronavirus Impact
The Zacks analyst is impressed with Walgreens' robust prescription sales growth in Retail Pharmacy USA. Yet, the company not providing its full-year outlook is concerning.
New Upgrades
Dollar General's (DG) Sturdy Comps Run to Propel Top-Line
Per the Zacks analyst, better price management, merchandise efforts, operational initiatives and coronavirus-led spike in demand should drive sales.
Jakafi Fuels Incyte (INCY) But Overdependence a Concern
Per the Zacks analyst, Incyte's lead drug Jakafi drives growth for the company on label expansion and approval of other drugs boost growth prospects. The company is highly dependent on Jakafi.
Take-Two (TTWO) Banks on Franchise Strength, User Addition
Per the Zacks Research analyst, expanding user base driven by strength in popular gaming franchises is aiding Take-Two's top-line amid rising competition.
New Downgrades
Coronavirus Woes and High SG&A Costs to Ail LKQ Corp (LKQ)
Low production and demand for vehicles in the wake of coronavirus is likely to weigh on the auto parts provider. High SG&A and manufacturing costs will also mar LKQ's margins, per the Zacks analyst.
Rising Expenses, High Debt Concern First American (FAF)
Per the Zacks analyst, First American's rising expenses drag margins. Also, high debt level and poor interest coverage implying that earnings are not sufficient to cover service debt concerns.
Rising Net Outflows, Concentration Risk Hurt Lazard (LAZ)
Per the Zacks analyst, rising net outflows hurt Lazard's assets under management growth.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
The Charles Schwab Corporation (SCHW) : Free Stock Analysis Report
Micron Technology, Inc. (MU) : Free Stock Analysis Report
Lockheed Martin Corporation (LMT) : Free Stock Analysis Report
Alphabet Inc. (GOOGL) : Free Stock Analysis Report
Bank of America Corporation (BAC) : Free Stock Analysis Report
Amazon.com, Inc. (AMZN) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research